ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Alzamend Neuro Inc

Alzamend Neuro Inc (ALZN)

1.00
-0.02
(-1.96%)
At close: March 28 04:00PM
1.00
-0.02
( -1.96% )
After Hours: 04:30PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.00
Bid
0.95
Ask
1.04
Volume
16,656
0.98 Day's Range 1.04
0.74 52 Week Range 11.91
Market Cap
Previous Close
1.02
Open
0.98
Last Trade
1
@
0.99
Last Trade Time
16:48:12
Financial Volume
$ 16,710
VWAP
1.0032
Average Volume (3m)
53,262
Shares Outstanding
7,120,703
Dividend Yield
-
PE Ratio
-0.49
Earnings Per Share (EPS)
-2.09
Revenue
-
Net Profit
-14.88M

About Alzamend Neuro Inc

Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Alzamend Neuro Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALZN. The last closing price for Alzamend Neuro was $1.02. Over the last year, Alzamend Neuro shares have traded in a share price range of $ 0.74 to $ 11.91.

Alzamend Neuro currently has 7,120,703 shares outstanding. The market capitalization of Alzamend Neuro is $7.26 million. Alzamend Neuro has a price to earnings ratio (PE ratio) of -0.49.

ALZN Latest News

Form 8-K - Current report

false --04-30 0001677077 0001677077 2024-03-07 2024-03-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares    ...

Form 8-K - Current report

false --04-30 0001677077 0001677077 2024-02-02 2024-02-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares    ...

Form 8-K - Current report

false 0001677077 0001677077 2024-01-05 2024-01-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

false --04-30 2024 Q2 0001677077...

Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients

Alzamend’s recently completed Phase IIA study of AL001 in Alzheimer’s patients and healthy subjects showed a benign safety profile and identified a candidate dose that is unlikely to require...

Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients

Alzamend’s recently completed Phase IIA study of AL001 in Alzheimer’s patients and healthy subjects showed a benign safety profile and identified a candidate dose that is unlikely to require...

Form 8-K - Current report

false 0001677077 0001677077 2023-11-16 2023-11-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED...

Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.04-3.846153846151.041.10170.953601402371.0195647CS
40.066.38297872340.941.290.90011038591.09511454CS
120.066.38297872340.941.290.74532621.03543743CS
26-2.516-71.5585893063.5163.8970.741403061.77720706CS
52-5.75-85.18518518526.7511.910.741610744.63334176CS
156-434-99.7701149425435503.250.74125493442.0301464CS
260-434-99.7701149425435503.250.74125493442.0301464CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QLIQilian International Holding Group Ltd
$ 1.02
(47.85%)
2.82M
SBFMSunshine Biopharma Inc
$ 0.08
(32.23%)
25.24M
GRTXGalera Therapeutics Inc
$ 0.176
(25.71%)
1.15M
MEDPMedpace Holdings Inc
$ 480.00
(18.77%)
1.41k
JSPRWJasper Therapeutics Inc
$ 0.2147
(17.97%)
600
XTKGX3 Holdings Company Ltd
$ 0.6769
(-31.63%)
1.25M
NDRAENDRA Life Sciences Inc
$ 0.46
(-20.69%)
131.57k
KYCHKeyarch Acquisition Corporation
$ 10.00
(-18.70%)
9.52k
NVVENuvve Holding Corporation
$ 0.90
(-18.18%)
137.24k
VVOSVivos Therapeutics Inc
$ 4.0497
(-16.16%)
54.49k
SBFMSunshine Biopharma Inc
$ 0.08
(32.23%)
25.24M
CRKNCrown Electrokinetics Corporation
$ 0.061
(1.84%)
7.08M
AAPLApple Inc
$ 171.2502
(-0.13%)
3.56M
JAGXJaguar Health Inc
$ 0.0859
(-4.45%)
3.2M
GMDAGamida Cell Ltd
$ 0.0378
(4.71%)
3.12M

ALZN Discussion

View Posts
Monksdream Monksdream 1 week ago
ALZN 10Q due 3/21
👍️0
Roozy Roozy 2 weeks ago
🤞🏼
👍️0
Monksdream Monksdream 2 weeks ago
ALZN 10Q due March 14
👍️0
Roozy Roozy 1 month ago
The pump then the dump
👍️0
Roozy Roozy 2 months ago
Another fake AULT stock
IPO @ $33
👍️0
Monksdream Monksdream 2 months ago
ALZN new 52=week low
👍️0
Roozy Roozy 2 months ago
Why the “1” trades ?
👍️0
Roozy Roozy 3 months ago
The AULT brand is poison!!!!!
👍️0
Roozy Roozy 3 months ago
It’s the manipulation
👍️0
zagdad zagdad 3 months ago
WTF...every time there is good news the pps seems to slide further...? Is it the AULT syndrome?
👍️0
Roozy Roozy 4 months ago
And then the news!!!!
Then the manipulation watch!!!!!
👍️0
Monksdream Monksdream 4 months ago
ALZN new 52 week low
👍️0
Roozy Roozy 4 months ago
Good news haha toilet dive
👍️0
Roozy Roozy 4 months ago
Smoke and mirrors compliance
An illusion
👍️0
Roozy Roozy 4 months ago
Hooray more good news
Aults lack of credibility means yawner
👍️0
Roozy Roozy 5 months ago
Defined how?
👍️0
Disquisition Disquisition 5 months ago
SAVAGE DUMPING
👍️0
Roozy Roozy 5 months ago
Trash
👍️0
Roozy Roozy 5 months ago
Another dishonest shell game to screw the shareholders. The SEC must nail this criminal manipulator.
👍️0
Roozy Roozy 5 months ago
So who make the med??
Cardinal Health??
Like b4
👍️0
glenn1919 glenn1919 6 months ago
ALZN.......................................https://stockcharts.com/h-sc/ui?s=ALZN&p=W&b=5&g=0&id=p86431144783
👍️0
Roozy Roozy 6 months ago
Remember PST??
This Co. must be sold to Johnson and Johnson for $7/share otherwise…
it’s dead
👍️0
Roozy Roozy 7 months ago
Biogeron anybody????
Snake oil????
👍️0
Monksdream Monksdream 7 months ago
ALZN new 52 week low
👍️0
Roozy Roozy 7 months ago
Way to go Todd
You f’d us AGAIN!!!!!!
👍️0
Roozy Roozy 7 months ago
Manny the Manipulator at work
Check who benefits
👍️0
Roozy Roozy 7 months ago
Timber!!$!!
👍️0
Roozy Roozy 8 months ago
Todd renders this OVER!!
👍️0
Roozy Roozy 8 months ago
I called the RS!!!!!
$1 or more or delisted
Watch Todd kill a ghost
Not funny
👍️0
Roozy Roozy 8 months ago
RS 3:1=appx $1.20 legal for continuation as a going concern
👍️0
Roozy Roozy 8 months ago
Delisting? Eh?
Fire up the race car
Deliver more bullshit!!!!!
👍️0
Roozy Roozy 8 months ago
I still own 12,500,000 shares of Biogeron
Look it up……BK too
wanna buy it?
👍️0
Roozy Roozy 8 months ago
Crookery in action
👍️0
Roozy Roozy 8 months ago
Way to go!! On the way to nowhere
Todd’s m.o. BK in 2008
👍️0
Roozy Roozy 9 months ago
Seminar?? To what end??
👍️0
Roozy Roozy 9 months ago
The price paid for success
👍️0
Roozy Roozy 9 months ago
Good newz death
👍️0
Roozy Roozy 9 months ago
Let’s go
👍️0
Roozy Roozy 10 months ago
Rumors perhaps??
👍️0
Roozy Roozy 12 months ago
Short of a “cure” this goes nowhere
👍️0
PennyStockTrader2 PennyStockTrader2 12 months ago
To date, I've made almost $10K trading the stock and writing the options, on top of that, riding 26K free shares as a result, plus founders shares (wont state quantity here, "never sold a share" of those as Todd likes to say). Pretty darned good, it's been a fair amount of work but also taking advantage of the options market at the right times. Not bad considering my first buys around $10/share, a miracle really.

BUT that Gig is over, the 2.50 calls, heck even November are not fetching anything, we are just too far away from a buck a share for anyone to think that 2.50 calls are worth the gamble to buy. At this point I am leaning towards simply buying shares around this price point or lower and selling on any rallies, not much else you can do with options off the table. The stock price is just cheap in my opinion and in fact I should have been buying this last month, I sort of lost track of the share price. But maybe at one point we rally and if we do maybe we can get a nickel for August or Nov in more than just small quantities. You can also try selling at the market and see where you get filled, but problem is they can fill you for a penny and then you are stuck with the options till expiration locking you from selling options on later rallies since all of these are covered calls and I cant really go naked.

On the prospects of the drug size, I am still bullish mostly on ALZ001 which seems like it should be a no-brainer. but this stuff takes so so long.
👍️0
Roozy Roozy 1 year ago
BF’nD!!
👍️0
Roozy Roozy 1 year ago
Gotta be for sale cheap!!
👍️0
Roozy Roozy 1 year ago
NO confidence vote here!!
👍️0
Roozy Roozy 1 year ago
The End approaches
👍️0
PennyStockTrader2 PennyStockTrader2 1 year ago
Continued to buy down to 50 cents, could that be a bottom, hell if I know, but it's a start. Problem is that options are off the table now, and the exchange wont add .50s or 1s, making hedging with the 2.50s almost impossible, the only one that can be written is the August 2.50s for maybe 15 cents, if you're lucky.
👍️0
Roozy Roozy 1 year ago
Oooooops to .58!!!!!!!!!
👍️0
Roozy Roozy 1 year ago
Oooooops to .6150!!!!!!
👍️0
Roozy Roozy 1 year ago
$33 birthday to .8396!!!!!
Sell off for $5/share
👍️0
PennyStockTrader2 PennyStockTrader2 1 year ago
I saw that, and I also see ALZN just fell off a cliff, I mean could that be related, people get nervous, there shouldnt be any relation whatsoever. Im buying right here at around 90 cents. Unfortunately the Feb 2.50 calls are no longer worth writing even if you could get a nickel, while the May 2.50s only fetch a dime, good thing I have written my fair share. Easy to look in hindsight and say why not write more, but you never never never know when this will spike. It has done it a few times and no reason to think we wont get a nice pump to drive up the price of options, when that happens do not be asleep at the wheel.
👍️0

Your Recent History

Delayed Upgrade Clock